A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

Researchers have discovered that DNA and RNA epigenetics form a complementary system that precisely regulates gene activity, ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

This is where DNA and RNA epigenetics comes in: a series of mechanisms that act as "markers" on genes, to control their ...